Thursday, June 13, 2024 8:43:17 PM
Recent SCLX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/26/2024 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/26/2024 01:38:08 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/25/2024 09:28:33 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/25/2024 09:28:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 09:19:25 PM
- Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report • GlobeNewswire Inc. • 07/24/2024 02:52:55 PM
- Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D. • GlobeNewswire Inc. • 07/23/2024 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/18/2024 08:20:36 PM
- Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in • GlobeNewswire Inc. • 07/17/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 05:53:34 PM
- Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination • GlobeNewswire Inc. • 07/02/2024 09:15:30 PM
- Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York • GlobeNewswire Inc. • 07/02/2024 01:00:00 PM
- Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024 • GlobeNewswire Inc. • 07/01/2024 01:00:00 PM
- Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. • GlobeNewswire Inc. • 06/20/2024 01:00:00 PM
- Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica) • GlobeNewswire Inc. • 06/14/2024 05:41:17 PM
- Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024 • GlobeNewswire Inc. • 06/13/2024 01:00:00 PM
- Pharma Shares Pop After Securing $100M Of Financing • AllPennyStocks.com • 06/12/2024 07:37:00 PM
- Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies • GlobeNewswire Inc. • 06/11/2024 11:20:12 PM
- Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA® • GlobeNewswire Inc. • 06/11/2024 01:00:00 PM
- Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S. • GlobeNewswire Inc. • 06/10/2024 03:49:02 PM
- Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024 • GlobeNewswire Inc. • 06/06/2024 06:56:09 PM
- Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company • GlobeNewswire Inc. • 05/30/2024 05:19:34 PM
- Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index • GlobeNewswire Inc. • 05/24/2024 05:40:58 PM
- Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company • GlobeNewswire Inc. • 05/24/2024 01:00:00 PM
- Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Pro • GlobeNewswire Inc. • 05/14/2024 01:00:00 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM